Europe

Guernsey releases marijuana regulations, licenses first business

A self-governing British Crown dependency in the English Channel updated its licensing regulations for CBD products and the cultivation of cannabis. Guernsey opened the door to medical cannabis and cannabidiol businesses last year by updating its Misuse of Drugs (Bailiwick of Guernsey) Law. Read the related updates for CBD here and here. Celebrated won the […]

Read More

Romania considering legalization of medical cannabis

A legal medical cannabis industry could be in Romania’s future, according to the country’s finance minister. Finance Minister Eugen Teodorovici said the Health Ministry launched a commission to analyze medical marijuana, Romanian television station Digi24 reported. According to the 24-hour news station, Teodorovici said: “I’ve talked to minister Sorina Pintea and found out that this […]

Read More

Canadian medical cannabis exports tripled last year, as race for European market position intensifies

Exports of medical cannabis from Canada soared last year as the country’s biggest licensed cannabis companies continued to establish beachheads in new medical markets overseas. Shipments of dried cannabis tripled to 1,460 kilograms (3,219 pounds) in 2018, compared with 500 kilograms in 2017 and only 44 kilograms in 2016. Exports of medical cannabis oil doubled […]

Read More

Insurance-covered cannabis in Germany tops 70 million euros in 2018

Statutory health insurers in Germany covered 73.7 million euros ($83.7 million) worth of medical cannabis products in 2018, according to new data published by German health insurance agency GKV-Spitzenverband. Pharmacies in the country processed 185,370 prescriptions under the statutory program – which covers roughly 90% of the population – during the year. Private prescriptions are […]

Read More

First medical cannabis clinic in United Kingdom opens

Britain’s first dedicated medical marijuana clinic opened in Manchester, setting the groundwork for wider use of MMJ in the country and sparking criticism from some quarters of the medical community. More clinics are expected to open in London and Birmingham later this spring, according to a news release. Only a handful of patients have had access […]

Read More

INCB Report: Certain medical cannabis programs violate international drug control treaties

Only a month after the World Health Organization recommended a less-stringent scheduling of cannabis, the United Nations International Narcotics Control Board (INCB) declared that recreational marijuana programs and several medical programs are “contrary to the international drug control treaties.” The INCB’s 2018 annual report could be a step back for those expecting meaningful reform at an international […]

Read More

Mold, labeling errors cause rash of cannabis recalls in Canada

A number of cannabis recalls over labeling errors and mold is a sign that the federal health department’s regulatory oversight is working, an industry representative said. Seven notices involving cannabis have been posted to Health Canada’s recall portal since Oct. 17, representing a fraction of the overall production. No recall notices were posted in the […]

Read More

Switzerland to embark on decade-long economic, social study of adult-use cannabis

Switzerland has proposed a pilot project to study the economic and health impacts of non-medical cannabis use, but any change in the country’s laws to create a sustainable adult-use cannabis industry could be years away. According to an amendment of Switzerland’s Narcotics Act currently before the country’s Parliament, the pilot project would allow up to […]

Read More

Aurora Cannabis targets European expansion with acquisition in Portugal

Edmonton, Alberta-based Aurora Cannabis advanced its strategy to attain “early mover advantage” in countries with nascent medical marijuana markets with an agreement to acquire a majority interest in a Portuguese license applicant. Under the terms of the agreement, Aurora will acquire a 51% ownership stake in Gaia Pharm – based in Funchal – to establish […]

Read More

UN Commission on Narcotic Drugs delays vote on WHO cannabis recommendations

The United Nations Commission on Narcotic Drugs (CND) will not vote on the World Health Organization’s cannabis recommendations at its March session in Vienna. That news comes after the release of the recommendations, which had been expected in December, was delayed. The proposal, made by the World Health Organization’s Expert Committee on Drug Dependence, could have […]

Read More

EU resolution’s medical cannabis definition too restrictive, experts say

While the European Parliament’s approval of a resolution to develop a European strategy for medical cannabis was well received by industry stakeholders, the business effects of the move may be less rosy for a rapidly evolving industry. “This is a missed opportunity,” Guillaume Balas, a member of the European Parliament (MEP) from France, wrote on […]

Read More

Canopy’s European cannabis production center expects first sales in September

Sales from Canopy Growth’s large cannabis production center in Denmark are expected to start in September, expanding the limited medical marijuana supply in the German market and giving a boost to the Canadian company’s international revenue. Canopy is among a number of major Canadian cannabis firms using Denmark as a springboard to meet soaring demand for medical […]

Read More